The following is a list of milestone documents, compiled by the National HPV Vaccination Roundtable, which chronicle notable events in U.S.-based HPV vaccine history, from 2006 to present.
FDA approves nine valent vaccination (9vHPV/Gardasil 9)
Gardasil 9 package insert: Link
National HPV Vaccination Roundtable established by the American Cancer Society and the Centers for Disease Control and Prevention
President’s Cancer Panel issues 2012-2013 Report: Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer
FDA licenses quadrivalent HPV vaccine (HPV4/Gardasil) for use in males aged 9 through 26 years for prevention of genital warts on October 16, 2009
Advisory Committee on Immunization Practices (ACIP) issues recommendations on quadrivalent HPV vaccine